BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9499826)

  • 1. [Paclitaxel].
    Díaz M; Campanero MA
    Rev Med Univ Navarra; 1996; 40(3):43-51. PubMed ID: 9499826
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials referral resource. Clinical trials with taxol.
    Cheson BD
    Oncology (Williston Park); 1992 Mar; 6(3):67-70. PubMed ID: 1348954
    [No Abstract]   [Full Text] [Related]  

  • 3. Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers.
    Dowell JE; Sinard R; Yardley DA; Aviles V; Machtay M; Weber RS; Weinstein GS; Chalian AA; Carbone DP; Rosenthal DI
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):97-101. PubMed ID: 10210547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
    Hájek R; Vorlicek J; Slavik M
    Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxol improves outlook for lung, breast, and ovarian cancer.
    Oncology (Williston Park); 1992 Aug; 6(8):16. PubMed ID: 1354469
    [No Abstract]   [Full Text] [Related]  

  • 6. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
    Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D
    Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A phase II clinical study of China-made paclitaxel in the treatment of cancer patients].
    Wu H; Guan Z; Lin T
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):148-52. PubMed ID: 10920970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Taxol in bronchial carcinoma].
    Gatzemeier U
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
    Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
    Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-intense paclitaxel: deja vu all over again?
    Takimoto CH; Rowinsky EK
    J Clin Oncol; 2003 Aug; 21(15):2810-4. PubMed ID: 12807932
    [No Abstract]   [Full Text] [Related]  

  • 11. Paclitaxel: current developmental approaches of the National Cancer Institute.
    Arbuck SG
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):55-63. PubMed ID: 8643972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
    Borovik R; Steiner M; Atad J; Sneiderman B; Rosenberg T; Palti S
    Harefuah; 1998 Apr; 134(8):605-8, 671. PubMed ID: 10911422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Taxol in the treatment of ovarian neoplasm].
    Wang Y; Huang R; Huang H
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):439-41. PubMed ID: 11360659
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aeroportia and necrotizing enteritis after chemotherapy with paclitaxel for lung carcinoma].
    Benoit L; Favoulet P; Fraisse J; Feutray S; Collin F; Chauffert B; Cuisenier J
    Gastroenterol Clin Biol; 2003 Apr; 27(4):423-4. PubMed ID: 12759687
    [No Abstract]   [Full Text] [Related]  

  • 15. Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.
    Akerley W; Herndon JE; Egorin MJ; Lyss AP; Kindler HL; Savarese DM; Sherman CA; Rosen DM; Hollis D; Ratain MJ; Green MR
    Cancer; 2003 May; 97(10):2480-6. PubMed ID: 12733147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel.
    Socinski MA; Schell MJ; Bakri K; Peterman A; Lee JH; Unger P; Yates S; Hudgens S; Kies MS
    Cancer; 2002 Sep; 95(6):1265-73. PubMed ID: 12216094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Taxotere in various solid tumors].
    Orel NF
    Vopr Onkol; 1998; 44(5):639-44. PubMed ID: 9925501
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of paclitaxel administration on P wave duration and dispersion.
    Barutcu I; Sezgin AT; Gullu H; Esen AM; Ozdemir R
    Clin Auton Res; 2004 Feb; 14(1):34-8. PubMed ID: 15045599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac dysfunction in cancer patients receiving paclitaxel.
    Valdés Olmos RA; ten Bokkel Huinink WW; Hoefnagel CA
    Eur J Nucl Med; 1998 Apr; 25(4):446-7. PubMed ID: 9643974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Paclitaxel].
    Hino M; Kudo S
    Nihon Rinsho; 2002 May; 60 Suppl 5():343-8. PubMed ID: 12101685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.